3 April 2008 in Veterinary Surgery
12 March 2004 in Veterinary Radiology & Ultrasound
A radiographic scoring system for features of osteoarthritis of the canine stifle joint was devised. Intra‐ and inter‐rater agreement was assessed by calculation of unweighted kappa statistics. “Global score,”“effusion”, “osteophytosis”, and “intra‐articular mineralization” were all features that had acceptable reliability, but “subchondral sclerosis” did not. The scoring system was used in a 13‐month prospective study of the radiographic progression of osteoarthritis of the stifle joint, secondary to cranial cruciate ligament deficiency, in 58 dogs. In the index stifle joints all features were characterized by significant change over time, but osteophytosis had the greatest degree of change. In addition, 40% of contralateral joints showed progressive osteophytosis.
20 February 2010 in Veterinary Record
The published, peer‐reviewed literature was systematically searched for information on the safety and efficacy of long‐term (defined as 28 days or more of continuous therapy) NSAID use in the treatment of canine osteoarthritis. Online databases were reviewed in June 2008 and papers were selected based on their relevance. Fifteen papers were identified and evaluated. Six of seven papers indicated a benefit of long‐term treatment over short‐term treatment in terms of the reduction of clinical signs or lameness; one study showed no benefit. Fourteen papers evaluated safety with calculated experimental (adverse) event rates (EER) between 0 and 0.31, but there was no correlation between study length and EER (rs=‐0.109, P=0.793). The balance of evidence for the efficacy of NSAIDs supports longer‐term use of these agents for increased clinical effect. There is no indication in the literature that such an approach is associated with a reduction in safety, although robust data on the safety of long‐term NSAID use are lacking in large numbers of dogs.
1 April 2005 in Critical Reviews in Food Science and Nutrition
There is growing recognition of the importance of nutritional factors in the maintenance of bone and joint health, and that nutritional imbalance combined with endocrine abnormalities may be involved in the pathogenesis of osteoarthritis (OA) and osteochondritis dissecans (OCD). Despite this, dietary programs have played a secondary role in the management of these connective tissue disorders. Articular cartilage is critically dependent upon the regular provision of nutrients (glucose and amino acids), vitamins (particularly vitamin C), and essential trace elements (zinc, magnesium, and copper). Therefore, dietary supplementation programs and nutraceuticals used in conjunction with non-steroidal, anti-inflammatory drugs (NSAIDs) may offer significant benefits to patients with joint disorders, such as OA and OCD. This article examines the available clinical evidence for the efficacy of nutraceuticals, antioxidant vitamin C, polyphenols, essential fatty acids, and mineral cofactors in the treatment of OA and related joint disorders in humans and veterinary species. This article also attempts to clarify the current state of knowledge. It also highlights the need for additional targeted research to elucidate the changes in nutritional status and potential alterations to the expression of plasma membrane transport systems in synovial structures in pathophysiological states, so that current therapy and future treatments may be better focused.
1 January 2005 in Journal of Orthopaedic Research